-
-
-
-
-
-
-
BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts
-
-
-
-
-
-
-
Lilly cuts Germany investment plan in half over healthcare reforms
-
-
-
-
-
-
-
BioNTech (BNTX) PT Raised to $130 at BofA Securities
-
-
-
-
-
-
-
BioNTech (BNTX) PT Lowered to $138 at Jefferies
-
-
-
-
-
-
-
Leerink Partners Downgrades BioNTech (BNTX) to Market Perform
-
-
-
-
-
-
-
FDA Probe Of Alleged Deaths Tied To Covid Shots Includes Adults
-
-
-
-
-
-
-
BioNTech (BNTX) PT Raised to $145 at Citi
-
479,635 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


